✉news BusinessStartups first seen 2 h ago, last 41 min ago, peak #26

Israeli startup DreaMed wins FDA nod for insulin-dosing app

Original: Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes

Israeli medtech startup DreaMed Diabetes has received FDA approval for an app that automatically adjusts insulin doses for people with Type 2 diabetes. The clearance lets the company bring its digital insulin-management tool to American patients, extending technology previously aimed at Type 1 diabetes. The news, reported by Calcalist, is being read as a milestone for Israeli digital health firms seeking US market entry.

Why now: Fresh FDA approval of an Israeli startup's diabetes app just made the news

DreaMed DiabetesFDAIsraelType 2 diabetes

Open on news →

Rank over time, top of the chart is #1. 2 snapshots from 2 h ago to 41 min ago.

Evidence

• Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes · calcalistech.com

API: https://socialmediatrends-api.osmike.com/v1/trends/277313